Oak Thistle LLC Purchases 314 Shares of Agilent Technologies, Inc. (NYSE:A)

Oak Thistle LLC grew its position in Agilent Technologies, Inc. (NYSE:AFree Report) by 8.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,121 shares of the medical research company’s stock after purchasing an additional 314 shares during the quarter. Oak Thistle LLC’s holdings in Agilent Technologies were worth $573,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Gotham Asset Management LLC boosted its stake in Agilent Technologies by 246.7% during the third quarter. Gotham Asset Management LLC now owns 54,437 shares of the medical research company’s stock worth $6,087,000 after buying an additional 38,737 shares in the last quarter. Global Retirement Partners LLC boosted its stake in Agilent Technologies by 65.6% during the third quarter. Global Retirement Partners LLC now owns 1,446 shares of the medical research company’s stock worth $161,000 after buying an additional 573 shares in the last quarter. Stifel Financial Corp boosted its stake in Agilent Technologies by 259.9% during the third quarter. Stifel Financial Corp now owns 119,582 shares of the medical research company’s stock worth $13,375,000 after buying an additional 86,355 shares in the last quarter. Natixis Advisors L.P. boosted its stake in Agilent Technologies by 20.9% during the third quarter. Natixis Advisors L.P. now owns 64,155 shares of the medical research company’s stock worth $7,174,000 after buying an additional 11,075 shares in the last quarter. Finally, Fulton Bank N.A. boosted its stake in Agilent Technologies by 2.2% during the third quarter. Fulton Bank N.A. now owns 9,106 shares of the medical research company’s stock worth $1,018,000 after buying an additional 193 shares in the last quarter.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. Bank of America downgraded shares of Agilent Technologies from a “buy” rating to a “neutral” rating and lifted their price target for the stock from $130.00 to $133.00 in a research note on Tuesday, December 12th. TheStreet raised Agilent Technologies from a “c+” rating to a “b-” rating in a report on Friday, December 8th. JPMorgan Chase & Co. lifted their price objective on Agilent Technologies from $140.00 to $165.00 and gave the company an “overweight” rating in a report on Wednesday, December 20th. Citigroup lifted their price objective on Agilent Technologies from $130.00 to $145.00 and gave the company a “neutral” rating in a report on Wednesday, February 28th. Finally, Oppenheimer lifted their price objective on Agilent Technologies from $67.00 to $90.00 and gave the company an “outperform” rating in a report on Tuesday, March 26th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and an average target price of $138.29.

Get Our Latest Stock Report on A

Insiders Place Their Bets

In other Agilent Technologies news, Director Heidi Fields sold 1,658 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $144.34, for a total transaction of $239,315.72. Following the completion of the sale, the director now directly owns 54,976 shares of the company’s stock, valued at approximately $7,935,235.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Heidi Fields sold 1,658 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $144.34, for a total transaction of $239,315.72. Following the completion of the transaction, the director now directly owns 54,976 shares in the company, valued at approximately $7,935,235.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Michael R. Mcmullen sold 52,297 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $150.00, for a total value of $7,844,550.00. Following the transaction, the chief executive officer now owns 253,909 shares of the company’s stock, valued at $38,086,350. The disclosure for this sale can be found here. In the last three months, insiders sold 61,610 shares of company stock valued at $9,220,333.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $143.73 on Thursday. The stock has a 50-day simple moving average of $139.08 and a 200 day simple moving average of $127.25. The company has a quick ratio of 2.04, a current ratio of 2.68 and a debt-to-equity ratio of 0.41. Agilent Technologies, Inc. has a 12-month low of $96.80 and a 12-month high of $151.58. The stock has a market capitalization of $42.12 billion, a price-to-earnings ratio of 34.22, a P/E/G ratio of 4.41 and a beta of 1.11.

Agilent Technologies (NYSE:AGet Free Report) last announced its quarterly earnings data on Tuesday, February 27th. The medical research company reported $1.29 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.07. The firm had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Agilent Technologies had a return on equity of 27.09% and a net margin of 18.35%. The company’s quarterly revenue was down 5.5% compared to the same quarter last year. During the same period in the previous year, the business posted $1.37 EPS. On average, research analysts anticipate that Agilent Technologies, Inc. will post 5.51 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 24th. Shareholders of record on Tuesday, April 2nd will be issued a dividend of $0.236 per share. The ex-dividend date is Monday, April 1st. This represents a $0.94 annualized dividend and a yield of 0.66%. Agilent Technologies’s dividend payout ratio is currently 22.38%.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Recommended Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.